Preclinical and translational data suggest that GLP-1 receptor agonism can reduce ethanol-related hepatoxicity by modulating ethanol metabolism and limiting the formation of toxic metabolites that drive hepatocellular injury
"Demand for the medications Mounjaro, Zepbound, Ozempic, and Wegovy (GLP-1 drugs) has skyrocketed, but supply shortages and high costs have created opportunities for wrongdoers to cash in and endanger consumers," they wrote.
Tirzepatide activates both GLP-1 and GIP receptors in the gut, which can slow digestion and cause loose stools in the first weeks of treatment
Weight regain isnt inevitable, but avoiding weight regain is one of the hardest parts of weight loss, with or without medication
[1] [2] The medication works by mimicking the action of naturally occurring GLP-1, a hormone that regulates blood glucose levels and appetite